Phlebitis: A swelling of veins, phlebitis can cause pain, tenderness, or swelling in the affected area as well as warmth and ...

As part of the transition to the new administration, CMS is reviewing its coverage policies for skin substitute products.

Celularity (CELU) welcomes action by the Centers for Medicare & Medicaid Services, or CMS, to revise to January 1, 2026, the effective date ...

Action delays to January 1, 2026, the effective date of a Biden-era Medicare LCD for skin substitute products used to treat diabetic foot ulcers and venous leg ulcersFLORHAM PARK, N.J., April 14, 2025 ...